Healthcare Wrap: Echo IQ and INOVIQ surge as funding and data drive the week

• Echo IQ jumped 29.80% after locking in a A$20 million Pro Medicus deal and US reseller agreement.
• INOVIQ rose 29.76% as lab data showed strong tumour kill in ovarian cancer cells.
• Imagion fell 20.00% even after raising cash for its US breast cancer trial, showing dilution still worries investors.
• AFT Pharmaceuticals posted strong FY26 growth and won FDA clearance for a pivotal injectable iron trial.